Гемохроматоз - современное состояние проблемы
- Авторы: Волошина Н.Б.1, Осипенко М.Ф.1, Литвинова Н.В.1, Волошин А.Н.2
-
Учреждения:
- Новосибирский государственный медицинский университет ФГБОУ ВО НГМУ Минздрава России
- Новосибирская городская клиническая больница №2
- Выпуск: Том 90, № 3 (2018)
- Страницы: 107-112
- Раздел: Передовая статья
- URL: https://journals.rcsi.science/0040-3660/article/view/32777
- DOI: https://doi.org/10.26442/terarkh2018903107-112
- ID: 32777
Цитировать
Полный текст
Аннотация
Ключевые слова
Полный текст
Открыть статью на сайте журналаОб авторах
Наталья Борисовна Волошина
Новосибирский государственный медицинский университет ФГБОУ ВО НГМУ Минздрава Россиик.м.н., доцент каф. пропедевтики внутренних болезней лечебного ф-та Новосибирск, Россия
Марина Федоровна Осипенко
Новосибирский государственный медицинский университет ФГБОУ ВО НГМУ Минздрава Россиид.м.н., проф., зав. каф. пропедевтики внутренних болезней лечебного ф-та Новосибирск, Россия
Наталья Владимировна Литвинова
Новосибирский государственный медицинский университет ФГБОУ ВО НГМУ Минздрава России
Email: Lina-2007@list.ru
к.м.н., доцент каф. пропедевтики внутренних болезней лечебного ф-та, orcid.org/0000-0002-9143-6330 Новосибирск, Россия
Андрей Николаевич Волошин
Новосибирская городская клиническая больница №2врач Новосибирской городской клинической больницы 2 Новосибирск, Россия
Список литературы
- EASL clinical practice guidelines for HFE hemochromatosis. Journal of Hepatology. 2010; 53: 3-22. https://doi.org/10.1016/j.jhep.2010.03.001
- Adams P, Brissot P, Powell L.W. EASL International consensus conference on haemochromatosis. Journal of Hepatology. 2000;33:487-496. https://doi.org/10.1016/s0168-8278(01)80874-6
- Bacon В.R, Adams P.C, Kowdley K.V, Powell L.W, Tavill A.S. Diagnosis and management of management of hemochromatosis: 2011 Practice Guideline by the American Association for the Study of Liver Diseases. Hepatolog. 2011; 54: 328-343. https://doi.org/10.1002/hep.24330
- Nemeth E, Ganz T. The role of hepcidin in iron metabolism. Acta Haematologica. 2009; 122: 78-86. https://doi.org/10.1159/000243791
- Nemeth E. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004; 306: 2090-2093. https://doi.org/10.1126/science.1104742
- Ganz T. Iron homeostasis: fitting the puzzle pieces together. Cell Metabolism. 2008; 7 (4): 288-290. https://doi.org/10.1016/j.cmet.2008.03.008
- Feder J.N, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy D.A, Basava A et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nature Genetics. 1996;13:399-408. https://doi.org/ 10.1038/ng0896-399
- Bardou-Jacquet E, de Tayrac M, Mosser J, Deugnier Y. GNPAT variant associated with severe iron overload in HFE hemochromatosis. Hepatology. 2015; 62 (6): 1917-1918. https://doi.org/10.1002/hep.27854
- Adams P.C, Barton J.C, Mc Laren G.D, Acton R.T, Speechley M, Mc Laren C.E et al. Screening for iron overload: lessons from the Hemochromatosis and IRon Overload Screening (HEIRS) Study. Canadian Journal of Gastroenterolgy. 2009; 23 (11): 769-772. https://doi.org/10.1155/2009/ 839308
- Adams P.C, Reboussin D.M, Barton J.C, Mc Laren C.E, Eckfeldt J.H, Mc Laren G.D et al. Hemochromatosis and iron - overload screening in a racially diverse population. New England Journal of Medicine. 2005; 352(17): 1769-1778. https://doi.org/10.1056/nejmoa041534
- Philippe M.A. Role of iron in hepatic fibrosis: one piece in the puzzle. World J Gastroenterol. 2007; 13 (35):4746. https://doi.org/10.3748/ wjg.v13.i35.4746
- Allen K.J et al. Iron - overload - related disease in HFE hereditary hemo - chromatosis. New England Journal of Medicine. 2008; 358 (21): 2293-2295. https://doi.org/10.1056/nejmc080330
- Asberg A, Hveem K, Thorstensen K. Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65,238 persons. Scand J Gastroenterol. 2001;36(10):1108-1115. https://doi.org/10.1080/003655201750422747
- Warne C.D, Zaloumis S.G, Bertalli N.A, Delatycki M.B et al. HFE p.C282Y homozygosity predisposes to rapid serum ferritin rise after menopause: A genotype - stratified cohort study of hemochromatosis in Australian women. J Gastroenterol Hepatol. 2017; 32 (4): 797-802. https://doi.org/10.1111/jgh.13621
- Powell L.W, Seckington R.C, Deugnier Y. Haemochromatosis. Lancet. 2016; 388(10045): 706-716. https://doi.org/10.1016/s0140-6736(15) 01315-x
- Wood M.J, Crawford D.H.G, Wockner L.F, Powell L.W, Ramm G.A. Serum ferritin concentration predicts hepatic fibrosis better than hepatic iron concentration in human HFE-Haemochromatosis. Liver International. 2017; 37(9): 1382-1388. https://doi.org/10.1111/liv.13395
- Allen K.J, Gurrin L.C, Constantine C.C et al. Iron - overload - disease in HFE hereditary hemochromatosis. New England Journal of Medicine. 2008; 358 (21): 2293-2295. https://doi.org/10.1056/nejmc080330
- Allen K.J et al. HFE C282Y homozygotes with serum ferritin concentrations below 1000 lg/l are et low risk of hemochromatosis. Hepatology. 2010; 52 (3): 925-933. https://doi.org/10.1002/hep.23786
- Moretti D, van Doorn G.M, Swinkels D.W, Melse-Boonstra A. Relevance of dietary iron intake and bioavailability in the management of HFE hemochromatosis: a systematic review. American Journal of Clinical Nutricion. 2013; 98 (2): 468-479. https://doi.org/10.3945/ ajcn.112.048264
- Harrison-Findik D.D, Schafer D, Klein E et al. Alcohol metabolism - mediated oxidative stress down - regulates hepcidin transcription and leads to increased duodenal iron transporter expression. Journal of Biological Chemistry. 2006; 281 (32): 22974-22982. https://doi.org/10.1074/ jbc.m602098200
- Harrison-Findik D.D, Klein E, Crist C, Evans J, Timchenko N, Gollan J. Iron - mediated regulation of liver hepcidin expression in rats and mice is abolished by alcohol. Hepatology. 2007;46(6):1979-1985. https://doi.org/10.1002/hep.21895
- Delatycki M.B, Gurrin L.C, Ong S.Y et al. Reduced mortality due to phlebotomy in moderately iron - loaded HFE haemochromatosis? The need for clinical trials. Journal of Hepatology. 2015;63(1):282-283. https://doi.org/10.1016/j.jhep.2015.03.028
- Stefashyna O, Stern M, Infanti L, Holbro A et al. Pattern of care of blood donors with early - uncomplicated hereditary haemochromatosis in a Swiss blood donation centre. Vox Sanguinis. 2013;106(2):111-117. https://doi.org/10.1111/vox.12078
- Phatak P, Brissot P, Wurster M et al. A phase 1/2, dose - escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosis. Hepatology. 2010;52(5):1671-1779. https://doi.org/ 10.1002/hep.23879
- Rombout-Sestrienkova E, van Kraaij M.G.J, Koek G.H. How we manage patients with hereditary haemochromatosis. British Journal of Haematology. 2016; 175(5): 759-770. https://doi.org/10.1111/bjh.14376